Systane Clinical Experience Study

Alcon

Status and phase: Completed; Phase 4

Conditions: Dry Eye Syndrome

Treatments: Other: Systane

Study type: Interventional

Funder types: Industry

Identifiers

NCT00818909

CARES-3

Details and patient eligibility

About

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Enrollment: 941 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• moderate to severe dry feeling eyes

Exclusion criteria

• None

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

941 participants in 1 patient group

Systane

Experimental group

Description:

Systane ocular product

Treatment:

Other: Systane